Braincells, Inc.
Records under this name other than patents Braincells, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Braincells, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,193,710 | Benzodiazepinones as modulators of metabotropic glutamate receptor functions and neurological uses thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,678,363 | Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs Lapsed on the fee record Ended Mar 16, 2018 · From the USPTO record | Lapsed on the fee record | Ended Mar 16, 2018 | From the USPTO record |
| US 7,678,808 | 5 HT receptor mediated neurogenesis Lapsed on the fee record Ended Mar 16, 2018 · From the USPTO record | Lapsed on the fee record | Ended Mar 16, 2018 | From the USPTO record |
| US 7,998,971 | Combinations containing a 4-acylaminopyridine derivative Lapsed on the fee record Ended Aug 16, 2015 · From the USPTO record | Lapsed on the fee record | Ended Aug 16, 2015 | From the USPTO record |
| US 7,985,756 | Modulation of neurogenesis by PDE inhibition Lapsed on the fee record Ended Jul 26, 2015 · From the USPTO record | Lapsed on the fee record | Ended Jul 26, 2015 | From the USPTO record |
| US 7,858,611 | Neurogenesis by modulating angiotensin Lapsed on the fee record Ended Dec 28, 2014 · From the USPTO record | Lapsed on the fee record | Ended Dec 28, 2014 | From the USPTO record |